SKK
ELDN icon

Shepherd Kaplan Krochuk’s Eledon Pharmaceuticals ELDN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-159
Closed -$267K – 391
2015
Q3 		$267K Buy
+159
New +$327K 0.07% 201

Other funds holding ELDN

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Shepherd Kaplan Krochuk's ELDN Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Eledon Pharmaceuticals (ELDN) in Q4 2015, closing a stake of 159 shares — an estimated $267K sold.

Shepherd Kaplan Krochuk first reported a position in ELDN in Q3 2015 and held it in 1 quarter. The position peaked at $267K in Q3 2015. 53 funds tracked by Wall St. Rank hold ELDN as of Q4 2015.

  • Shepherd Kaplan Krochuk reported no remaining Eledon Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 159 Eledon Pharmaceuticals shares in Q4 2015, an estimated $267K.
  • Shepherd Kaplan Krochuk first reported a position in Eledon Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's Eledon Pharmaceuticals position peaked at $267K in Q3 2015.
  • 53 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.